SNWVSANUWAVE Health, Inc.
Is SANUWAVE Health struggling financially?
Yes, by its own account. SANUWAVE Health told the SEC on 29 Apr 2026, in Form DEF 14A, that there is substantial doubt about its ability to continue as a going concern. It generated cash over the last twelve months rather than burning it, so the doubt here is about something other than an empty bank account.
Going concern disclosed Apr 2026
30/100
Fragile
- Sector
- Biotech/Pharma
- Market cap
- $39.7M
- Source filing
- DEF 14A 29 Apr 2026
- Balance sheet
- 30 Jun 2026
Cash runway
No net burn
This company generated cash over the last twelve months, so there is no burn rate to divide by. Going concern language in this position is usually about debt coming due or a covenant.
What it reported
Cash and short-term investments
$9.4M
What SANUWAVE Health told the SEC
…its reports on the consolidated financial statements for the years ended December 31, 2024 and 2023, Marcum included a paragraph regarding the existence of substantial doubt about our ability to continue as a going concern. During the years ended December 31, 2024 and 2023, and through April 10, 2025, the date of Marcum’s resignation, there were (a) no disagreements (as defined in Item 304(a)(1)(iv) of…
SANUWAVE Health, Inc., Form DEF 14A, filed 29 Apr 2026.
Read the filing on SEC.govWhat this means
- Not a bankruptcy filing, and not a prediction.
- It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
- The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.
Other Biotech/Pharma companies that filed the doubt
- MLSS Milestone Scientific $42.7M
- MOBI Mobia Medical $353.2M
- PIII P3 Health Partners $74.9M
- PLYX Polaryx Therapeutics $103.2M
- SCLX Scilex Holding Company $48.7M
- TXMD TherapeuticsMD $23.8M